Linnaeus Therapeutics
Development stage biotech company.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD82m (Public information from Jan 2023)
Haddonfield New Jersey (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
$300k | Grant | ||
| N/A | $2.2m | Early VC | |
$12.0m | Series B | ||
| N/A | $4.3m | Series C | |
* | N/A | $3.1m Valuation: $60.0m | Late VC |
| N/A | $1.6m | Late VC | |
| Total Funding | CAD32.1m | ||
Related Content
Recent News about Linnaeus Therapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.